Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VA TECH WABAG vs SUN PHARMA ADV. RES. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VA TECH WABAG SUN PHARMA ADV. RES. VA TECH WABAG/
SUN PHARMA ADV. RES.
 
P/E (TTM) x 11.0 -27.0 - View Chart
P/BV x 1.0 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VA TECH WABAG   SUN PHARMA ADV. RES.
EQUITY SHARE DATA
    VA TECH WABAG
Mar-22
SUN PHARMA ADV. RES.
Mar-22
VA TECH WABAG/
SUN PHARMA ADV. RES.
5-Yr Chart
Click to enlarge
High Rs404349 115.9%   
Low Rs230142 161.5%   
Sales per share (Unadj.) Rs479.15.0 9,489.9%  
Earnings per share (Unadj.) Rs21.7-7.5 -290.6%  
Cash flow per share (Unadj.) Rs23.4-7.1 -328.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs247.5-7.5 -3,314.1%  
Shares outstanding (eoy) m62.19271.88 22.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.748.6 1.4%   
Avg P/E ratio x14.6-32.8 -44.4%  
P/CF ratio (eoy) x13.6-34.6 -39.3%  
Price / Book Value ratio x1.3-32.9 -3.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m19,72266,767 29.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,507968 259.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m29,7931,372 2,170.7%  
Other income Rs m33368 486.3%   
Total revenues Rs m30,1261,441 2,090.7%   
Gross profit Rs m2,361-1,867 -126.4%  
Depreciation Rs m101102 99.7%   
Interest Rs m877133 658.0%   
Profit before tax Rs m1,716-2,034 -84.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3630-   
Profit after tax Rs m1,352-2,034 -66.5%  
Gross profit margin %7.9-136.1 -5.8%  
Effective tax rate %21.20-   
Net profit margin %4.5-148.2 -3.1%  
BALANCE SHEET DATA
Current assets Rs m29,638712 4,165.4%   
Current liabilities Rs m21,6931,714 1,265.4%   
Net working cap to sales %26.7-73.1 -36.5%  
Current ratio x1.40.4 329.2%  
Inventory Days Days113272 41.5%  
Debtors Days Days1,624738 220.2%  
Net fixed assets Rs m10,0242,089 479.8%   
Share capital Rs m124272 45.8%   
"Free" reserves Rs m15,267-2,302 -663.1%   
Net worth Rs m15,391-2,030 -758.1%   
Long term debt Rs m9360-   
Total assets Rs m39,6622,801 1,416.1%  
Interest coverage x3.0-14.3 -20.7%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.80.5 153.3%   
Return on assets %5.6-67.9 -8.3%  
Return on equity %8.8100.2 8.8%  
Return on capital %15.993.6 17.0%  
Exports to sales %26.40-   
Imports to sales %00-   
Exports (fob) Rs m7,851NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,85150 15,635.5%   
Fx outflow Rs m3,9882,712 147.1%   
Net fx Rs m3,862-2,662 -145.1%   
CASH FLOW
From Operations Rs m116-2,082 -5.6%  
From Investments Rs m-340-292 116.5%  
From Financial Activity Rs m4462,293 19.5%  
Net Cashflow Rs m213-81 -263.6%  

Share Holding

Indian Promoters % 6.1 69.1 8.8%  
Foreign collaborators % 15.6 0.0 -  
Indian inst/Mut Fund % 18.6 3.2 589.2%  
FIIs % 15.4 2.4 639.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 78.3 30.9 253.3%  
Shareholders   113,411 94,494 120.0%  
Pledged promoter(s) holding % 0.0 2.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster


More on VA TECH WABAG vs SUN PHARMA ADV. RES.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VA TECH WABAG vs SUN PHARMA ADV. RES. Share Price Performance

Period VA TECH WABAG SUN PHARMA ADV. RES. S&P BSE CAPITAL GOODS
1-Day 2.09% -1.26% 2.32%
1-Month -8.60% -2.35% -5.05%
1-Year -23.31% -24.26% 19.82%
3-Year CAGR -0.69% 21.96% 20.41%
5-Year CAGR -15.37% -10.45% 12.85%

* Compound Annual Growth Rate

Here are more details on the VA TECH WABAG share price and the SUN PHARMA ADV. RES. share price.

Moving on to shareholding structures...

The promoters of VA TECH WABAG hold a 21.7% stake in the company. In case of SUN PHARMA ADV. RES. the stake stands at 69.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VA TECH WABAG and the shareholding pattern of SUN PHARMA ADV. RES..

Finally, a word on dividends...

In the most recent financial year, VA TECH WABAG paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SUN PHARMA ADV. RES. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of VA TECH WABAG, and the dividend history of SUN PHARMA ADV. RES..

For a sector overview, read our engineering sector report.



Today's Market

4 Reasons Why Sensex Surged 1,277 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and registered healthy gains.